FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

ALPA Share Price Discussion

Alpa Laboratories Ltd.
NSE: ALPA | BSE: 532878 | ISIN: INE385I01010 | Sector: Pharmaceuticals and health care

ALPA Rating

0/5 (0 Ratings)
ALPA Share Price *
20.35 +0.45 (2.26%)
* (quote may be delayed)
Find answers to all your questions on live ALPA message board: Is ALPA buy or sell? Should I buy ALPA shares? Why are ALPA shares falling? Should I invest in ALPA stock?

You can also check ALPA share price target recommended by brokerages.

ALPA Discussion Forum


I'm holding Alps Labs since long @ 29/-. Should I hold it or exit?
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
  • ALPA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization55.76
    Enterprise Value56.34
    Price to Earnings17.23
    Price to Book Value0.53
    Return on Capital Employed0.07
    Return on Equity0.05
    Face Value10
    Dividend YieldNA
  • ALPA Share Price - Technicals

    keyboard_arrow_down
    ALPA - 52 Week High₹30.4
    ALPA - 52 Week Low₹13.2
  • ALPA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 1419.521.5519.3520.25
    Feb 1319.5521.219.1519.9
    Feb 12202019.119.2
    Feb 1119.620.519.319.6
    Feb 1020.520.51919.6
  • ALPA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹20.28
    30 Day Moving Average₹19.28
    50 Day Moving Average₹17.85
    100 Day Moving Average₹16.7
    200 Day Moving Average₹17.88
  • ALPA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue61.5565.61-0.06
    Operating Profit3.954.97-0.21
    Profit Before Tax6.538.65-0.25
    Net Income4.755.72-0.17
  • ALPA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds105.91103.210.03
    Total Liabilities22.6923.33-0.03
    Total Assets128.6126.540.02
  • ALPA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-7.2514.91-1.49
    Cash from Investing Activity-15.821.09-15.51
    Cash from Financing Activity4.41-16.23-1.27
    Net Cash Flow-18.66-0.2476.75
  • ALPA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.040.04
    Return on Equity0.050.06
    Return on Capital Employed0.070.09
  • ALPA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.07
    3 Year CAGR Growth in Operating Profit0.15
    3 Year CAGR Growth in EBIDTA0.73
    3 Year CAGR Growth in Net Income4.39
    3 Yr CAGR Growth - Diluted EPS4.37
  • ALPA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.1
    5 Year CAGR Growth in Operating Profit0.32
    5 Year CAGR Growth in EBIDTA1.52
    5 Year CAGR Growth in Net Income2.09
    3 Yr CAGR Growth - Diluted EPS2.09
  • ALPA - Recent News

    keyboard_arrow_down
  • ALPA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.